SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001485003-16-000185
Filing Date
2016-09-28
Accepted
2016-09-28 16:14:00
Documents
1
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_147509362699302.html 3  
1 FORM 3 wf-form3_147509362699302.xml 3 3023
  Complete submission text file 0001485003-16-000185.txt   4600
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MILNER AVENUE, SUITE 914 TORONTO A6 M1B3V4
Business Address 305 MILNER AVENUE, SUITE 914 TORONTO A6 M1B3V4 416-940-6995
Clairmark Investments Ltd. (Reporting) CIK: 0001652078 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 161907093